As you will see, the reviewers appreciate the high quality of your work and provide constructive input on how to further strengthen it. We would thus like to invite you to submit a revised version to us, addressing the individual points raised by the reviewers. Please assess the effects of RNA and heparin (reviewer #1). Please also provide better insight into the potential physiological significance in planta (reviewer #3).
To upload the revised version of your manuscript, please log in to your account: https://lsa.msubmit.net/cgi-bin/main.plex You will be guided to complete the submission of your revised manuscript and to fill in all necessary information. Please get in touch in case you do not know or remember your login name.
We would be happy to discuss the individual revision points further with you should this be helpful.
While you are revising your manuscript, please also attend to the below editorial points to help expedite the publication of your manuscript. Please direct any editorial questions to the journal office.
The typical timeframe for revisions is three months. Please note that papers are generally considered through only one revision cycle, so strong support from the referees on the revised version is needed for acceptance.
When submitting the revision, please include a letter addressing the reviewers' comments point by point.
We hope that the comments below will prove constructive as your work progresses.
Thank you for this interesting contribution to Life Science Alliance. We are looking forward to receiving your revised manuscript.
Sincerely, Andrea Leibfried, PhD Executive Editor Life Science Alliance Meyerhofstr. 1 69117 Heidelberg, Germany t +49 6221 8891 502 e a.leibfried@life-science-alliance.org www.life-science-alliance.org
---------------------------------------------------------------------------

A. THESE ITEMS ARE REQUIRED FOR REVISIONS
--A letter addressing the reviewers' comments point by point.
--An editable version of the final text (.DOC or .DOCX) is needed for copyediting (no PDFs).
--High-resolution figure, supplementary figure and video files uploaded as individual files: See our detailed guidelines for preparing your production-ready images, http://www.life-sciencealliance.org/authors --Summary blurb (enter in submission system): A short text summarizing in a single sentence the study (max. 200 characters including spaces). This text is used in conjunction with the titles of papers, hence should be informative and complementary to the title and running title. It should describe the context and significance of the findings for a general readership; it should be written in the present tense and refer to the work in the third person. Author names should not be mentioned.
B. MANUSCRIPT ORGANIZATION AND FORMATTING:
Full guidelines are available on our Instructions for Authors page, http://www.life-sciencealliance.org/authors We encourage our authors to provide original source data, particularly uncropped/-processed electrophoretic blots and spreadsheets for the main figures of the manuscript. If you would like to add source data, we would welcome one PDF/Excel-file per figure for this information. These files will be linked online as supplementary "Source Data" files. ***IMPORTANT: It is Life Science Alliance policy that if requested, original data images must be made available. Failure to provide original images upon request will result in unavoidable delays in publication. Please ensure that you have access to all original microscopy and blot data images before submitting your revision.***
This manuscript describes a careful and comprehensive study on the structure and function of CHAD domains. These protein domains had previously no assigned function. The authors demonstrated convincingly that these domains bind the polyanion polyP. The authors solved the structure of various CHAD domains, and conducted careful mutagenesis studies to define the client specificity. Finally, the authors expressed CHAP-mcherry fusions in Arabidopsis to illustrate the potential application of this fusion to detect polyP in vivo.
I have only a few minor and one slightly more major comment that need to be addressed: 1) the authors might want to consider using one of their purified CHAD domains (ideally the one with the highest affinity for polyP) and conduct affinity measurements with RNA and heparin. Both are frequently interfering with polyP detection in vivo. This becomes particularly important since the authors see the CHAD-domain to form foci in the nucleus/nucleolus.
2) It is not completely obvious from the graph why the authors speculate that RcCHAD also behaves like an oligomer. There is some impurity in the protein-could this explain the appearance of 2 peaks? 3) Fig. 3B /5E -the authors might want to explain why their y-axis range is so different 4) label "B" in fig. 5B should be above the first panel on the right. 5) there are several issues with the IF data: -it is unclear why the signal of the CHAD-mcherry is so much higher in the PPK expressing cells than in the cells that either do not express PPK or express the mutant? Wouldn't one expect a much brighter signal in those cells which gets more diffuse as polyP accumulates in the cytosol? Is it possible that the expression of active PPK affects the expression level of CHAD-mcherry? Westernblot analysis should be presented to show that all cells express the same level of CHADmcherry and, in the respective cells, the same amount of wildtype and mutant PPK.
-nuclear marker need to be included -the right and left panels seem not to be in focus Reviewer #2 (Comments to the Authors (Required)):
The authors set out to examine the structure of the CHAD domains from bacterial, archaeal, and eukaryotic origin and report that they are polyphosphate binding domains. The authors found dissociation constants ranging from the nano-to mid-micromolar range. Mutational analyses of CHAD-polyP validated the complex structure. They localized the domain to the nucleus and nucleolus of plant cells. This is a thoughtfully considered and well executed study. Overall, this manuscript advances the field significantly as it stands. I have only minor suggestions.
Line 43: blood coagulation Line 189 (and other places): amino acids (separated) Line 229: polyphosphate is also present in the nucleolus of trypanosomes (Negreiros et al., Mol. Microbiol. 110 973-996, 2018 Reviewer #3 (Comments to the Authors (Required)):
In the work the authors undertook the characterization of the conserved CHAD domain present in all three kingdoms of life. They convincingly demonstrate that the CHAD is a polyP binding domain that does not seem to have an intrinsic polyP hydrolyzing activity, but may enhance the enzymatic activity of polyphosphatases (ygiF) or may be involved in localizing polyP to the nucleus and the nucleolus in plant cells. The work seems technically sound and of high standard using state of the art technology.
Hence, my comments relate to the general significance of the work. 1) The hypothesis of a role of the CHAD domain in polyp metabolism/localization in plants is interesting but the authors do not show any evidence that polyphosphates indeed exist in plants. Indeed, the CHAD domain is often associated with proteins containing a TTM domain, which in some cases (bacteria for instance) is a enzymatically competent polyphosphatase. However, plant (A. taliana) TTM3 is a tripolyphosphatase and not a long chain polyphosphatase. Could the CHAD domain also bind short chain poly(tri)phosphates ?
2) Another point is that, according to my understanding of the manuscript, the only higher plant where a CHAD domain has been identified is Ricinus communis. The CHAD domain seems to be absent in A. taliana for instance. This suggests that, at least in plants, the CHAD domain is of limited importance and its presence in R. communis may be linked to some peculiarities of Ricinus secondary metabolism. Could polyphosphates have a specific role in this species?
For the reader not familiar with plant biology (such as this reviewer) it would be interesting to discuss these possibilities. In addition, and in view of the above arguments (mainly absence of proof for the existence of polyP in plants, CHAD documented in only one plant species), I feel that the main conclusion of the manuscript (i.e. last four line of the abstract) is somewhat overinterpreted as far as plants are concerned, but may be correct in prokaryotes. 1. We have reformatted the manuscript to meet LSA style (figure labels and sizes, reference format) 2. We have shortened the abstract to 173 words.
3. We have added a summary blurb (lines 9-11) that reads: "A domain of unknown function termed CHAD, present in all kingdoms of life, is characterized as a specific inorganic polyphosphate binding domain."
4.
We have added a conflict of interest statement.
5.
We have renamed the methods section to meet LSA style and reordered the manuscript according to your formatting suggestions.
6. Data availability: The crystallographic structure factors and coordinates have been deposited with the Protein Data Bank. The stable RcCHAD-mCherry transgenic line will be deposited with the NASC stock center. Expression constructs will be deposited with Addgene. Full blots and gels are shown in figures 1D, 2D, 3E, 6D. For the biochemical GCI binding assays, raw traces are presented in figures 3, 5 and S7. All other materials including the raw confocal images have been compiled and will be available upon request.
Response to Reviewer #1:
OUR RESPONSE:
We thank reviewer #1 for her/his suggestion. We further tested the ligand specificity of CtCHAD against biotinylated RNA (a polyG 10mer) and biotinylated heparin, and using biotinylated polyP as a control in quantitative GCI assays. The results are shown in revised Figure 3D and are described in the revised text (lines 136-139): "...and we could not observe detectable binding of SsCHAD or RcCHAD to GCI chips coated with biotinylated single-stranded DNA or RNA (Fig. 3D) . However, heparin, which is absent in bacteria and plants, was bound by CtCHAD with binding constants comparable to polyP (Fig 3D) ."
We have added a statement in our discussion that highlights the fact that heparin binds to CHAD domains and also to the known polyP-'specific' dyes DAPI and JC-D7/8 (lines 208-213): "Binding appeared specific, with the exception of heparin, which binds CtCHAD with high affinity but is absent in CHAD domain-containing organisms. It is of note that heparin also binds to the known polyPspecific dyes DAPI (Kolozsvari et al, 2014) and JC-D7/8 (Angelova et al, 2014) . To our knowledge, heparin binding to the polyP-binding domain from E. coli PPX1, which is used to detect polyP in immunofluorescence assays, has not been tested (Saito et al, 2005) ."
2) It is not completely obvious from the graph why the authors speculate that RcCHAD also behaves like an oligomer. There is some impurity in the protein-could this explain the appearance of 2 peaks?
Indeed there is an impurity in all our RcCHAD preparations, which appears to co-purify with the plant CHAD domain expressed in E. coli. We found the RcCHAD protein contained in both peaks shown in the analytical size exclusion chromatography experiments in Figure 2D . We have purified RcCHAD again to performed SEC-RALS analysis (as shown for the well-behaving CtCHAD in Fig. S8 ).
However, the protein degrades during the run at the required column temperature of 35 deg C. We thus have removed the statement referring to the oligomeric state of RcCHAD from the manuscript. The revised section now reads (lines 107-108): "…with ygiF and SsCHAD behaving as monomers, while unliganded CtCHAD form dimers in solution (Figs 2D and S8, see Discussion) ." 3) Fig. 3B /5E -the authors might want to explain why their y-axis range is so different OUR RESPONSE These apparent discrepancies can be explained by the different CHAD proteins being used in the assays presented in Figures 3B versus 5E . The observed differences in surface mass originate from different protein concentrations used as analytes in the different assays. These differences do not affect the accuracy of the IC50 values derived from these experiments. fig. 5B should be above the first panel on the right.
4) label "B" in
OUR RESPONSE
Corrected.
5) there are several issues with the IF data: OUR RESPONSE:
We apologize for not having explained this experiment better in our manuscript. The data shown in Fig.   6 represent live imaging confocal microscopy of fluorescently tagged RcCHAD and EcPPK1 proteins expressed in Nicotiana benthamiana leaves.
-it is unclear why the signal of the CHAD-mcherry is so much higher in the PPK expressing cells than in the cells that either do not express PPK or express the mutant? Wouldn't one expect a much brighter signal in those cells which gets more diffuse as polyP accumulates in the cytosol?
OUR RESPONSE:
These experiments were done by transiently expressing the respective fusion proteins in tobacco. In this system expression varies greatly from cell to cell. Thus this method can be used to study the sub- Westernblot analysis should be presented to show that all cells express the same level of CHADmcherry and, in the respective cells, the same amount of wild-type and mutant PPK.
OUR RESPONSE
We performed western blot analysis of tobacco leaves infiltrated with (i) RcCHAD alone, (ii) RcCHAD and EcPPK1, and (iii) RcCHAD and EcPPK1 mutant (revised Figure 6D) . We detect single bands migrating at the predicted molecular weights of RcCHAD and EcPPK1. Hence, the fluorescent signals correspond to full-length RcCHAD-mCherry and EcPPK1-mCitrine, and are not derived from free mCherry or free mCitrine, respectively.
We observe that RcCHAD expression is higher in leaves infiltrated with only RcCHAD than in leaves co-infiltrated with RcCHAD and EcPPK1. We cannot discard that EcPPK1 expression might affect RcCHAD expression. Nevertheless, the aim of this experiment was to examine if RcCHAD co-localizes with PPK1-derived granules, not to compare proteins levels, for which this experiment is not suited (see above). The localization of RcCHAD does not depend on its protein levels, since cells from different leaves infiltrated with RcCHAD showed different fluorescent intensity.
In order to control proteins levels, we would need to generate single transgenic Arabidopsis lines for the different proteins, select lines with comparable protein levels, and then obtain genetic crosses between them. This is a very time-consuming experiment, which is further complicated by the fact that PPK1 expression in Arabidopsis is highly toxic (https://www.biorxiv.org/content/10.1101/630129v1).
-nuclear marker need to be included
We have performed the suggested control experiment, which is shown in revised Figure 6B . We used DAPI, which stains the nucleus of plant cells (see for instance Gallem í et al., Development 2016) but not the nucleolus (Sirri et al., Histochem Cell Biol. 2008) . We find that RcCHAD-mCherry co-localizes with DAPI in the nucleus of tobacco cells, and shows a higher signal in the nucleolus (which is not stained by DAPI). When RcCHAD is co-expressed with EcPPK1, both proteins co-localize to cytosolic granules which do not correspond to chloroplasts (as judged from the chlorophyll autofluorescence) (Fig. 6A,C) . Thus, DAPI staining confirms the nuclear localization of isolated RcCHAD-mCherry.
-the right and left panels seem not to be in focus OUR RESPONSE
We have included Z-stacks in our revised Fig. 6A to account for this.
Reviewer #2:
The authors set out to examine the structure of the CHAD domains from bacterial, archaeal, and eukaryotic origin and report that they are polyphosphate binding domains. The authors found dissociation constants ranging from the nano-to mid-micromolar range. Mutational analyses of CHAD-polyP validated the complex structure. They localized the domain to the nucleus and nucleolus of plant cells. This is a thoughtfully considered and well executed study. Overall, this manuscript advances the field significantly as it stands. I have only minor suggestions. OUR RESPONSE This is the correct term.
Reviewer #3:
Hence, my comments relate to the general significance of the work.
1) The hypothesis of a role of the CHAD domain in polyp metabolism/localization in plants is interesting, but the authors do not show any evidence that polyphosphates indeed exist in plants.
OUR RESPONSE
There are a number of early studies that report polyP stores in higher plants (for example Miyachi (1961) J Biochem, 50:4-367-371). We have recently used the polyP-specific dye JC-D7 and the polyPbinding domain from EcPPX1 to localize polyPs in plant cells and tissues, but only found significant stores in the green algae Chlamyodomonas. From this, we conclude that there are no highly concentrated polyP granules in higher plants, at least not under the growth conditions and tissues tested (https://www.biorxiv.org/content/10.1101/630129v1).
The accumulation of RcCHAD in the nucleus/nucleolus region of plant cells however suggests that polyP might exist in these cellular compartments. This hypothesis needs to be tested in future studies.
We have thus toned down our abstract accordingly, which now reads (lines 22-25): "The presence of a CHAD domain in the polyPase ygiF enhances its enzymatic activity. The only known CHAD protein from the plant Ricinus communis localizes to the nucleus/nucleolus when expressed in Arabidopsis and tobacco, suggesting that plants may harbor polyPs in these compartments. We propose that CHAD domains may be used to engineer the properties of polyP-metabolizing enzymes and to specifically localize polyP stores in eukaryotic cells and tissues." Indeed, the CHAD domain is often associated with proteins containing a TTM domain, which in some cases (bacteria for instance) is a enzymatically competent polyphosphatase. However, plant (A. taliana) TTM3 is a tripolyphosphatase and not a long chain polyphosphatase. Could the CHAD domain also bind short chain poly(tri)phosphates?
We analyzed binding of CtCHAD to tripolyphosphate in competition assays. We observe that CtCHAD also binds tripolyphosphate, showing a similar IC50 that the one obtained for a polyP 7mer (see revised Figure 5E ).
2) Another point is that, according to my understanding of the manuscript, the only higher plant where a CHAD domain has been identified is Ricinus communis. The CHAD domain seems to be absent in A. thaliana for instance. This suggests that, at least in plants, the CHAD domain is of limited importance and its presence in R. communis may be linked to some peculiarities of Ricinus secondary metabolism.
Could polyphosphates have a specific role in this species? For the reader not familiar with plant biology (such as this reviewer) it would be interesting to discuss these possibilities.
OUR RESPONSE Indeed, we speculate that RcCHAD might have been acquired by Ricinus via horizontal gene transfer from bacteria. Genes acquired in this way can either maintain the same function in the host organism or adopt a new one. We could thus far not detect polyP granules in Ricinus (shown in Figure S4 In addition, and in view of the above arguments (mainly absence of proof for the existence of polyP in plants, CHAD documented in only one plant species), I feel that the main conclusion of the manuscript (i.e. last four line of the abstract) is somewhat overinterpreted as far as plants are concerned, but may be correct in prokaryotes.
We fully agree with reviewer #3' assessment. We have revised the respective statement in our abstract (lines 22-26), which now reads: "The only known CHAD protein from the plant Ricinus communis localizes to the nucleus/nucleolus when expressed in Arabidopsis and tobacco, suggesting that plants may harbor polyPs in these compartments. We propose that CHAD domains may be used to engineer the properties of polyP-metabolizing enzymes and to specifically localize polyP stores in eukaryotic cells and tissues." Thank you for submitting your revised manuscript entitled "Molecular characterization of CHAD domains as inorganic polyphosphate binding modules". As you will see, the reviewers appreciate your point-by-point response and the introduced changes and we would thus be happy to publish your paper in Life Science Alliance. Please log into our system one more time to fill in the electronic license to publish form. Your new manuscript number will be LSA-2019-00385-TRR, please make sure to carry over all manuscript files to this new number (single click process).
If you are planning a press release on your work, please inform us immediately to allow informing our production team and scheduling a release date.
To upload the final version of your manuscript, please log in to your account: https://lsa.msubmit.net/cgi-bin/main.plex You will be guided to complete the submission of your revised manuscript and to fill in all necessary information. Please get in touch in case you do not know or remember your login name.
To avoid unnecessary delays in the acceptance and publication of your paper, please read the following information carefully.
A. FINAL FILES:
These items are required for acceptance.
--High-resolution figure, supplementary figure and video files uploaded as individual files: See our detailed guidelines for preparing your production-ready images, http://www.life-sciencealliance.org/authors --Summary blurb (enter in submission system): A short text summarizing in a single sentence the study (max. 200 characters including spaces). This text is used in conjunction with the titles of papers, hence should be informative and complementary to the title. It should describe the context and significance of the findings for a general readership; it should be written in the present tense and refer to the work in the third person. Author names should not be mentioned.
